My site

Takeda Highlights Data from Clinical Trial of Investigational Norovirus Vaccine CResults of Phase 1/2 Study Show Reduction in Disease Severity Following Challenge with Live Norovirus, Provides Evidence for Further Investigation

SAN FRANCISCO & OSAKA, Japan - Saturday, October 5th 2013 [ME NewsWire]

IDWeek 2013

(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (Takeda) announced today results of a Phase 1/2 study of its intramuscular bivalent (GI/GII) norovirus vaccine candidate in healthy adult volunteers who were challenged with the most commonly occurring norovirus (genotype GII.4) that causes gastroenteritis. The study demonstrated that two doses of the experimental bivalent norovirus were well tolerated, and that the candidate vaccine had a clinically relevant impact on the incidence of norovirus illness after challenge, as well as the severity in breakthrough cases. In addition to the impact on clinical illness, a positive trend toward reduction in ... Read more »

FINDLAY, Ohio - Saturday, October 5th 2013 [ME NewsWire]

(BUSINESS WIRE)-- Cooper Tire & Rubber Company (NYSE: CTB) today filed a complaint in Delaware Chancery Court asking that subsidiaries of Apollo Tyres Ltd (NSE: ApolloTYRE) be required to expeditiously close the pending merger between the two tire companies in accordance with the terms of the definitive merger agreement.

Cooper stockholders voted overwhelmingly to approve the pending merger on Monday, September 30, satisfying Cooper’s final affirmative condition under the merger agreement for closing the $2.5 billion, all-cash transaction. The pending merger was announced on June 12 after the boards of directors of both companies unanimously approved the sale of Cooper to a wholly-owned subsidiary of Apollo for $35 per share.

Cooper is asking the court to compel Apollo to take actions so that the transaction may close. Among other matters, the complaint says that Apollo is seeking to delay an agreement wi ... Read more »

Clinical study validates previous feasibility study results identifying Alzheimer’s patients via beta amyloid signature in the eyes

LONDON - Friday, October 4th 2013 [ME NewsWire]

(BUSINESS WIRE) Inventages announces that one of its portfolio companies, Cognoptix, has demonstrated unprecedented accuracy in detecting Alzheimer's disease. A multi-site clinical trial of the SAPPHIRE II eye test showed a sensitivity of 85% and a specificity of 95% in differentiating Alzheimer’s disease patients from healthy volunteers.

The Cognoptix test involves a simple eye test that detects beta-amyloid, the hallmark of Alzheimer’s disease. This test is significantly differentiated from other blood or imaging tests in being:

    Simple and non-invasive to perform
    Quick, taking less than 5 minutes
    Detects the defining hallmark of Alzheimer’s disease, not a surrogate biomarker
    Generates an easy to ... Read more »

ME NewsWire / BusinessWire

Partnership Aligns Two Global Companies with Exciting New Lineups

HOUSTON - Sunday, October 6th 2013

The Houston Rockets and ZTE USA, the fastest-growing smartphone provider in the United States, jointly announced their first partnership, making ZTE the official smartphone of the Houston Rockets for the 2013-14 NBA season. The partnership is the first of its kind for ZTE globally and the first big consumer marketing push in the U.S. since the company entered the States 15 years ago.

As part of the partnership, ZTE will have an opportunity to engage directly with the fans of the Rockets around the world through a variety of avenues, including key Rockets events, television and digital exposure, and customized in-game activation

Both the Rockets and ZTE brands are debuting new, more powerful lineups this year. ZTE is launching two new smartphones – the ZTE Grand S and the ZTE nubia 5 – while the Rockets have a highly anticipa ... Read more »